viimane versioon :
19/11/2024
mitmesugune   Cromoglycate sodium  
aerosool
Stabiilsust ravimpreparaadid Stabiilsust mõjutavad tegurid stabiilsust mõjutavad faktorid Sobimatus Viited pdf
   keemiline struktuur  

aerosool
Viited   aerosool   Viited : Cromoglycate sodium  
tüüp avaldamine
549 ajaleht Owsley HD, Rusho WJ.
Compatibility of common respiratory therapy drug combinations.
Int J Pharm Compound 1997 ; 1: 121-122.
665 ajaleht Blondino, FE, Baker M.
Stability of Nebulizer Admixtures.
Int J Pharm Compound 2005 ; 9, 4: 323-326.
2550 ajaleht Roberts GW, Rossi S.O.P.
Compatibility of nebulizer solutions
Aust J Hosp Pharm 1993 ; 23: 35-37.
2774 ajaleht McKenzie J.E, Mario Cruz-Rivera M.
Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions.
Ann Pharmacotherapy 2004 ; 38: 967-972.
2803 ajaleht Bonasia PJ, McVicar WK, Williams B, Ong S.
Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium.
Respiratory Care 2008 ; 683, 12: 1716-1722.
3498 ajaleht Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M
Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424.

  Mentions Légales